Pharmaceutical composition based on taxoids

US5670536A · kind A · utility

Assignee

• RHONE-POULENC RORER S.A. · FR

Inventors

• Manfred Durr · Bad Sobernheim, DE
• Jorg Hager · Cologne, DE
• Armin Wendel · Cologne, DE

Key dates

• Filing date: Apr 25, 1995
• Grant date: Sep 23, 1997
• Expiry date: Apr 25, 2015

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P35/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

This invention relates to a pharmaceutical composition comprising as active principle, docetaxel or a taxoid derived from docetaxel, one or more unsaturated phospholipids and a small amount of one or more negative phospholipids, allow the active principle to be formulated in high concentration and are suitable for administration by injection.